Company page

Abl Bio, Inc.

Abl Bio, Inc. is a public company listed under the ticker 298380 on the Korean market. The company has a market capitalization of approximately 4.26 trillion KRW. It focuses on biopharmaceuticals and innovative treatments, contributing to advancements in healthcare.

profile298380AI content: aiUpdated May 30, 2026/company/abl-bio-inc
Abl Bio, Inc. logo
Ticker
298380
Market cap
$4.26B
Sector
Health Technology
Industry
Pharmaceuticals: Major